ACGA
MDT icon

Atlanta Consulting Group Advisors’s Medtronic MDT Stock Holding History

Atlanta Consulting Group Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,926
Closed -$283K – 157
2025
Q4 		$283K Hold
2,926
– – 0.06% 136
2025
Q3 		$281K Buy
2,926
+507
+21% +$46.6K 0.07% 114
2025
Q2 		$213K Hold
2,419
– – 0.06% 126
2025
Q1 		$219K Sell
2,419
-507
-17% -$45.4K 0.06% 114
2024
Q4 		$234K Sell
2,926
-1,826
-38% -$158K 0.09% 113
2024
Q3 		$428K Buy
4,752
+1,769
+59% +$149K 0.11% 145
2024
Q2 		$235K Hold
2,983
– – 0.05% 105
2024
Q1 		$260K Buy
+2,983
New +$255K 0.09% 109

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atlanta Consulting Group Advisors's MDT Position: Q1 2026 in Review

Atlanta Consulting Group Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,926 shares — an estimated $283K sold.

Atlanta Consulting Group Advisors first reported a position in MDT in Q1 2024 and held it in 8 quarters. The position peaked at $428K in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Atlanta Consulting Group Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Atlanta Consulting Group Advisors sold 2,926 Medtronic shares in Q1 2026, an estimated $283K.
  • Atlanta Consulting Group Advisors first reported a position in Medtronic in Q1 2024 and held it in 8 quarters.
  • Atlanta Consulting Group Advisors's Medtronic position peaked at $428K in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.